ArticleACS omega2026
pH-Dependent Conformational Changes in Grb2 Monomer Reveal Different Binding Sites for Coumarin: An Insight for Small Molecule Drug Discovery.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growth factor receptor-bound protein 2 (Grb2) is an essential adaptor protein that mediates activation of the RAS/mitogen-activated protein kinase (MAPK) signaling cascade by linking receptor tyrosine kinase to the guanine nucleotide exchange factor SOS (Son of Sevenless). Grb2 exists in a dynamic monomer-dimer equilibrium, with only the monomer competent for signaling. Dysregulation of this pathway is common in cancer, making Grb2 a compelling therapeutic target. Coumarin, a plant-derived compound with reported anticarcinogenic activity, was previously shown to bind the SH2 domain of dimeric Grb2. Here, we investigated the interaction between coumarin and the monomeric form of Grb2 under two physiologically relevant pH conditions (7 and 8), corresponding to healthy and cancer cell environments, respectively. Fluorescence quenching, dynamic light scattering, and STD-NMR analyses revealed that pH modulates Grb2's conformation, increasing its hydrodynamic diameter and exposing alternative ligand-binding sites. The interaction mapping identified Trp60 (buried in the dimeric form) as a key contact residue and at pH 8.0, coumarin binds Grb2 with a 10-fold higher stability. These findings demonstrate, for the first time, that coumarin interacts with monomeric Grb2 and that pH-sensitive structural dynamics modulate ligand binding. Our results highlight the importance of mimicking disease-relevant physicochemical conditions in ligand discovery efforts and support the development of pH-sensitive inhibitors targeting aberrant MAPK signaling in cancer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.